Clinical Trial Update: Magnesium Supplementation for Hypomagnesemia in Chronic Kidney Disease [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating magnesium supplementation for hypomagnesemia in chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• Hypomagnesemia

Drugs mentioned

• Magnesium supplement (Magnesium)

Snippet

Sponsor: Zealand University Hospital | Conditions: Chronic Kidney Disease, Hypomagnesemia | Phase 1, Phase 2 | Status: COMPLETED